Skip to content

Clinical trials

Urogenital Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20101
20111
20141
20151
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Steba Biotech S.A.3
Aragon Pharmaceuticals, Inc.1
Arno Therapeutics1
Astellas Pharma Global Development, Inc.1
Bioniche Life Sciences Inc.1
Blue Earth Therapeutics Ltd1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Pfizer1
Queen Mary University of London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms12
Prostatic Neoplasms9
Genital Neoplasms, Male7
Neoplasms7
Neoplasms by Site7
Prostatic Diseases7
Genital Diseases, Male6
Male Urogenital Diseases5
Carcinoma3
Genital Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.